Cairo – Mubasher: Minapharm Pharmaceuticals reported a decline of 57.4% in net profits for the third quarter of 2016.
Minapharm recorded net profits of EGP 10.8 million ($655,000) in Q3-16, down from EGP 25.35 million ($1.53 million) in the same period of the previous year.
The unconsolidated results of the company showed a 43% decline in the net profits of the first nine months of 2016 to EGP 37.14 million, compared to EGP 65.18 million in the prior-year period.
